---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-037610"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2026-08-13T13:00:44+00:00"
generated_at: "2026-08-13T13:02:09.227176+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biofrontera Q2 revenue up 33% to $12.0M; net loss narrows to $0.6M

## Summary
- Q2 net product revenue $12.0M, up 32.9% YoY; gross margin 80% vs 71% prior year.
- Net loss narrowed to $0.6M ($0.05/share) from $5.3M ($0.57/share); Adjusted EBITDA $(0.2)M vs $(5.1)M.
- H1 revenue $22.1M (+25.4%); operating cash use cut 76% to $1.7M; cash $4.7M at June 30.
- ITC exclusion order on RhodoLED XL lamp effective July 7, 2026; remediation plan underway, full-year revenue goals unchanged.
- PDUFA date late September 2026 for sBCC indication; launch expected Q1 2027 if approved.

## SEC filing metadata
- accession: 0001493152-26-037610
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2026-08-13T13:00:44+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315226037610/0001493152-26-037610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315226037610/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-037610
- JSON: https://secwatch.observer/filing/0001493152-26-037610.json
- Plain text: https://secwatch.observer/filing/0001493152-26-037610.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.